-
1دورية أكاديمية
المؤلفون: Børge G Nordestgaard, Tom M Palmer, Marianne Benn, Jeppe Zacho, Anne Tybjaerg-Hansen, George Davey Smith, Nicholas J Timpson
المصدر: PLoS Medicine, Vol 9, Iss 5, p e1001212 (2012)
مصطلحات موضوعية: Medicine
وصف الملف: electronic resource
-
2
المؤلفون: Vanita R. Aroda, Srikanth Bellary, Gurudutt Nayak, Yutaka Seino, Jeppe Zacho, L.H. Damgaard, Robert Silver, Helena W. Rodbard, Irene Hramiak
المصدر: Endocrine Practice. 25:589-597
مصطلحات موضوعية: medicine.medical_specialty, Insulin glargine, business.industry, Endocrinology, Diabetes and Metabolism, Semaglutide, General Medicine, Type 2 diabetes, medicine.disease, Gastroenterology, chemistry.chemical_compound, Endocrinology, chemistry, Weight loss, Internal medicine, Sitagliptin, medicine, Dulaglutide, Glycated hemoglobin, medicine.symptom, business, Exenatide, medicine.drug
-
3
المؤلفون: Vanita R. Aroda, Morten Donsmark, Trine Saugstrup, Jeppe Zacho, John B. Buse, Melanie J. Davies
المصدر: Diabetes, Obesity & Metabolism
مصطلحات موضوعية: medicine.medical_specialty, Population level, Endocrinology, Diabetes and Metabolism, Population, Glucagon-Like Peptides, 030209 endocrinology & metabolism, Review Article, 030204 cardiovascular system & hematology, Placebo, Glucagon-Like Peptide-1 Receptor, law.invention, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Randomized controlled trial, law, Internal Medicine, estimand, Medicine, Humans, education, Intensive care medicine, Review Articles, Randomized Controlled Trials as Topic, education.field_of_study, Models, Statistical, business.industry, Semaglutide, GLP‐1 receptor agonists, PIONEER, Diabetes, regulatory guidance, 3. Good health, Discontinuation, Clinical trial, Diabetes Mellitus, Type 2, Estimand, oral semaglutide, business
-
4
المؤلفون: Ludger Rose, Cyrus Desouza, Thomas R. Pieber, Jeppe Zacho, Thomas Kruse Hansen, Ildiko Lingvay, Katarina Lalic
المصدر: Diabetes Care. 41:1926-1937
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Placebo, Gastroenterology, Drug Administration Schedule, law.invention, Placebos, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Diabetes mellitus, Internal medicine, Internal Medicine, medicine, Clinical endpoint, Humans, Exercise, Aged, Glycated Hemoglobin, Advanced and Specialized Nursing, Liraglutide, business.industry, Semaglutide, Middle Aged, medicine.disease, Combined Modality Therapy, Metformin, Diet, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7abea7067ce96def980ae4df3bca4ab9
https://doi.org/10.2337/dc17-2381 -
5
المؤلفون: Vincent Woo, Jeffrey Unger, Srikanth Bellary, O Hansen, Cyrus Desouza, J. Hans DeVries, Jeppe Zacho
المساهمون: Endocrinology, AGEM - Endocrinology, metabolism and nutrition
المصدر: Diabetes, obesity & metabolism, 20(10), 2426-2434. Wiley-Blackwell
Diabetes, Obesity & Metabolismمصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, endocrine system diseases, Gastrointestinal Diseases, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Weight Gain, Placebo, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, Humans, Multicenter Studies as Topic, Medicine, Adverse effect, Aged, Randomized Controlled Trials as Topic, Retrospective Studies, Glycated Hemoglobin, business.industry, Insulin glargine, Semaglutide, Original Articles, Middle Aged, medicine.disease, Hypoglycemia, glycaemic control, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Sitagliptin, Original Article, Female, type 2 diabetes, medicine.symptom, business, GLP‐1, Exenatide, Weight gain, hypoglycaemia, medicine.drug
وصف الملف: application/pdf
-
6
المؤلفون: Steen H. Ingwersen, Anne Flint, Jeppe Zacho, Rune Viig Overgaard, Kristin C. Carlsson Petri
المصدر: Diabetes, Obesity & Metabolism
مصطلحات موضوعية: Blood Glucose, Male, Diabetes duration, Phase iii trials, Endocrinology, Diabetes and Metabolism, Population, Glucagon-Like Peptides, Physiology, 030209 endocrinology & metabolism, Type 2 diabetes, Body weight, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, GLP‐1 analogue, Weight loss, Weight Loss, Internal Medicine, medicine, Humans, Hypoglycemic Agents, 030212 general & internal medicine, education, Exposure response, Randomized Controlled Trials as Topic, Glycated Hemoglobin, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Semaglutide, Original Articles, Middle Aged, medicine.disease, Treatment Outcome, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Female, Original Article, type 2 diabetes, medicine.symptom, business, GLP‐1
-
7
المؤلفون: Kristin C. Carlsson Petri, Anne Flint, Rune Viig Overgaard, Jeppe Zacho, Steen H. Ingwersen
المصدر: Diabetes Therapy
مصطلحات موضوعية: medicine.medical_specialty, GLP-1 receptor agonist, Endocrinology, Diabetes and Metabolism, Population, 030209 endocrinology & metabolism, Type 2 diabetes, GLP-1 analog, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Internal medicine, Diabetes mellitus, Internal Medicine, Medicine, Population pharmacokinetics, 030212 general & internal medicine, education, Glucagon-like peptide 1 receptor, Original Research, education.field_of_study, business.industry, Maintenance dose, Semaglutide, Type 2 Diabetes Mellitus, medicine.disease, business
-
8
المؤلفون: Yuichiro Yamada, Tomoyuki Nishida, Hirotaka Watada, Atsuko Abiko, Arihiro Kiyosue, Jeppe Zacho, Kohei Kaku
المصدر: Diabetes, Obesity & Metabolism
مصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, Drug Resistance, Glucagon-Like Peptides, Administration, Oral, Type 2 diabetes, 030204 cardiovascular system & hematology, law.invention, 0302 clinical medicine, Endocrinology, Japan, Randomized controlled trial, law, Weight loss, randomized trial, Clinical endpoint, Biguanide, Middle Aged, Combined Modality Therapy, glycaemic control, Original Article, Drug Therapy, Combination, Female, type 2 diabetes, Drug Monitoring, medicine.symptom, medicine.medical_specialty, medicine.drug_class, Injections, Subcutaneous, 030209 endocrinology & metabolism, Drug Administration Schedule, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, GLP‐1 analogue, Internal medicine, Diabetes mellitus, Weight Loss, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Adverse effect, Aged, Glycated Hemoglobin, Dose-Response Relationship, Drug, business.industry, Semaglutide, Original Articles, medicine.disease, phase III study, Hypoglycemia, Diabetes Mellitus, Type 2, Hyperglycemia, incretin therapy, business, Follow-Up Studies
-
9
المؤلفون: Jeppe Zacho, Yasuhiko Iwamoto, Kenichi Yamada, Jan Ekelund, Yukiko Onishi
المصدر: Journal of Diabetes Investigation
مصطلحات موضوعية: Insulin degludec, Blood Glucose, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, 030209 endocrinology & metabolism, Type 2 diabetes, Hypoglycemia, Insulin aspart, 03 medical and health sciences, 0302 clinical medicine, Japan, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Humans, Hypoglycemic Agents, 030212 general & internal medicine, Insulin Aspart, Aged, Insulin degludec/insulin aspart, business.industry, Insulin, General Medicine, Articles, Middle Aged, medicine.disease, Clinical Trial, Confidence interval, Insulin, Long-Acting, Endocrinology, Clinical Science and Care, Treatment Outcome, Basal (medicine), Diabetes Mellitus, Type 2, Japanese, Female, business, medicine.drug
-
10